Skip to main content
. 2017 Aug 3;38(11):1554–1565. doi: 10.1038/aps.2017.54

Table 2. Pharmacokinetic parameters of zidovudine (AZT) after oral administration of 20 mg/kg AZT or intravenous administration of 10 mg/kg AZT to acute liver failure (ALF) rats and age-matched control (CON) rats. Data are expressed as mean±SD. n=6. *P<0.05, **P<0.01 vs CON rats.

Group CON ALF
Oral administration    
k (1/h) 0.65±0.08 0.37±0.04**
t1/2 (h) 1.07±0.15 1.91±0.22**
Tmax (h) 0.71±0.10 0.54±0.10*
Cmax (μg/mL) 5.72±0.70 7.76±0.88**
AUC0-t (μg·h·mL−1) 10.74±1.28 16.14±2.52**
AUC0-∞ (μg·h·mL−1) 10.82±1.29 16.53±2.52**
Vz/F (L/kg) 2.89±0.44 3.43±0.89
CL/F (L·h−1) 1.87±0.23 1.23±0.19**
MRT (h) 1.83±0.19 2.55±0.11**
Intravenous administration    
k (1/h) 1.57±0.13 0.88±0.13**
t1/2 (h) 0.44±0.04 0.80±0.13**
C0 (μg/mL) 14.15±2.52 17.74±3.83**
AUC0-t (μg·h·mL−1) 8.09±1.42 12.39±1.28**
AUC0-∞ (μg·h·mL−1) 8.17±1.43 12.57±1.34**
Vz (L/kg) 0.76±0.16 0.75±0.06
CL (L·h−1) 1.25±0.20 0.80±0.08**
MRT (h) 0.61±0.07 0.94±0.08**